Former Alaris CEO To Head Cardinal’s Clinical Technologies & Services Group
This article was originally published in The Pink Sheet Daily
Executive Summary
David Schlotterbeck will oversee the new group, which incorporates clinical services & consulting, automation & information services and the newly acquired Alaris. Cardinal expects the reorganization to take place by Sept. 30.
You may also be interested in...
Cardinal CFO Departs Amidst SEC, U.S. Attorney Investigations
Board member J. Michael Losh will serve as interim CFO, effective immediately. Former CFO Richard Miller will help in the transition, Cardinal says, but will not be involved in preparing financial statements or SEC filings.
Cardinal Health Accounting Probe Has Broad Focus
SEC investigation into Cardinal's accounting practices is not limited to the vitamin price-fixing settlement. Investigation could have a ripple effect across industry; inquiry coincides with rise of inventory management agreements.
Able Unable To Reform On Its Own? Firm Seeks Consent Decree To Address Manufacturing Issues
“We are prepared to enter discussions toward a decree at FDA’s earliest convenience,” Able says in letter to FDA. Company is pursuing consent decree instead of responding to FDA Form 483 report citing manufacturing deficiencies. The letter follows CEO Maury’s resignation the previous day.